Charles Schwab Investment Management Inc Entrada Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 203,693 shares of TRDA stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203,693

Previous 192,717 5.7%

Holding current value

$1.3 Million

Previous $1.74 Million 21.47%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.72 - $9.23 $73,758 - $101,308	10,976 Added 5.7%	203,693 $1.37 Million
Q1 2025 Sep 15, 2025	SELL	$9.04 - $18.31 $99,223 - $200,970	-10,976 Reduced 5.39%	192,717 $1.74 Million
Q1 2025 May 09, 2025	SELL	$9.04 - $18.31 $39,866 - $80,747	-4,410 Reduced 2.24%	192,717 $1.74 Million
Q4 2024 Feb 06, 2025	BUY	$15.82 - $21.59 $176,282 - $240,577	11,143 Added 5.99%	197,127 $3.41 Million
Q3 2024 Nov 12, 2024	BUY	$13.65 - $17.86 $322,726 - $422,263	23,643 Added 14.56%	185,984 $2.97 Million
Q2 2024 Aug 12, 2024	BUY	$11.85 - $16.45 $67,687 - $93,962	5,712 Added 3.65%	162,341 $2.31 Million
Q1 2024 May 08, 2024	BUY	$11.58 - $17.0 $61,038 - $89,607	5,271 Added 3.48%	156,629 $2.22 Million
Q4 2023 Feb 06, 2024	SELL	$11.36 - $16.99 $43,917 - $65,683	-3,866 Reduced 2.49%	151,358 $2.28 Million
Q3 2023 Nov 08, 2023	BUY	$13.61 - $18.01 $174,303 - $230,654	12,807 Added 8.99%	155,224 $2.45 Million
Q2 2023 Aug 09, 2023	BUY	$11.02 - $18.01 $583,387 - $953,431	52,939 Added 59.16%	142,417 $2.16 Million
Q1 2023 May 11, 2023	BUY	$9.58 - $16.2 $4,866 - $8,229	508 Added 0.57%	89,478 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$13.52 - $22.89 $15,020 - $25,430	1,111 Added 1.26%	88,970 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$9.65 - $15.76 $434,993 - $710,413	45,077 Added 105.36%	87,859 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$5.49 - $12.94 $142,311 - $335,430	-25,922 Reduced 37.73%	42,782 $522,000
Q1 2022 May 13, 2022	BUY	$7.99 - $16.93 $37,433 - $79,317	4,685 Added 7.32%	68,704 $646,000
Q4 2021 Feb 11, 2022	BUY	$13.7 - $35.0 $877,060 - $2.24 Million	64,019 New	64,019 $1.1 Million

Others Institutions Holding TRDA

# of Institutions

106

Shares Held

28.8M

Call Options Held

15.7K

Put Options Held

View Full List

About Entrada Therapeutics, Inc.

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $200M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

More about TRDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Entrada Therapeutics, Inc. Transaction History